1. Home /
  2. Pharmaceuticals

Pharmaceuticals

An Experienced Hand Launches 3 ETFs Under His Own Flag

ETF veteran Kevin Kelly is the force behind Kelly ETFs, which this month introduced three funds with distinctly different focuses.

Johnson & Johnson May Shed Some Tears in This Bear Market Decline

JNJ has been in a longer-term uptrend but that may not be enough to keep the rally going.

Buy Moderna? A Subscriber Wants to Know

Let's take a look at the charts and indicators.

Fast Track or Slow Track, I Still Believe in Genprex's Long-Term Story

This health biotech has been dealt some tough hands, but is still at the table. Here's my take.

BioMarin Pharmaceutical Is Ready to Start a Fresh Advance

Here's where aggressive traders could go long BMRN.

Zoetis Could Be Seeing Its Correction Coming to an End

The shares of the animal health company could be finding a bottom after losing substantial ground since the start of the year.

CVS Is a Good Place to Hide in a Volatile Marketplace: What Traders Can Do

The firm certainly seems to have the wind at its sails right now.

Walgreens Boots Alliance Is Ready to Break Out of Its Lengthy Consolidation

Here's where traders could go long.

Caution Signs Are Flashing in My Mind as the New Year Begins

The biotech sector looks ripe for staging a comeback, but a significant geopolitical event could throw the entire market for a loop.

Options Play of the Week: Take a Chance on This Small Biopharma in 2022

After a huge drop in recent weeks, these shares look oversold -- and an insider seems to agree.